Properties

  • Title:
    A Polish company from the biotechnological sector offers its business for sale under acquisition agreement.
  • Business profile
  • OFFER from Poland, reference: BOPL20190920002, valid from 24-09-2019 untill 02-10-2020
  • Created:
    3 oktober 2019
  • Updated:
    14 oktober 2019

General information

  • Reference:
    BOPL20190920002
  • Profile type
    BCD offer
  • Country of origin:
    Poland
  • Deleted
    Nee
  • Status:
    Update
  • Start date:
    24 september 2019
  • End date:
    2 oktober 2020

Business profile

  • Description:
    The Polish company, located in south-west Poland was established in 2018 and is one of the innovative regional companies in the biotechnological trade.

    The company products portfolio include:
    - Innovation technology: universal transdermal drug carrier - formula adjusted to the particular molecule.
    - Innovation technology: a transport system created on the basis of non-aggregating molecules to increase the surface area of the release of solid drug form.
    - Drug candidate: local anesthetic ointment
    - Drug candidate: tissue regeneration ointment
    - Drug candidate: propriate drug for breast cancer treating

    Thanks to the use of the company's technology, the industry partner gains a competitive advantage by introducing in the short term a medicinal product in a new form of application (transdermal), which will allow i. a.: level side effects of the drug, reduce the dose of the active substance, work longer or more precisely. With the use of innovative technology, drugs currently applied with tablets and injections, can be served by using patches and ointments.

    Currently the company focuses on the development of patent-protected medicines and technologies. In order to strengthen the company's position on international markets, this SME is looking for an acquirer interested in part/full acquisition.
  • Technologie keywords
    • Biology / Biotechnology
  • Activity codes
    • Research and experimental development on biotechnology
    • Other research and experimental development on natural sciences and engineering
    • Other human health activities
  • Languages
    • English
    • Polish
  • Preferred countries
    • Austria
    • Belgium
    • Bulgaria
    • China
    • Croatia
    • Cyprus
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • Ireland
    • Italy
    • Japan
    • Latvia
    • Lithuania
    • Netherlands
    • New Zealand
    • Portugal
    • Romania
    • Slovakia
    • Slovenia
    • Korea, Republic of
    • Spain
    • Sweden
    • United States

More information

  • Plus Value:
    With more than thirty years of experience, the R&D company team is able to effectively create proprietary medicines, solve complex technological problems and create unique solutions to help people all over the world.

    The combination of company technology with existing on the market solutions, recipes or active substances creates a unique and unrepeatable quality, which will be protected by a patent cloud, securing products of business partners.

    The SME also provides research and development services for pharmaceutical, biotechnological, cosmetic and chemical companies from all over the world.
  • IPR Status:
    Patents granted
  • EOI Status:
    Yes
  • Experience:

Organisation

  • Type of organisation:
  • Since:
    2018
  • Type and Size:
    Industry SME = 10
  • Transnational
    Nee
  • Turnover:
    1M

Collaboration

  • Technical Specification or Expertise Sought:
    pppThis Polish company is looking for a partner, that would be interested in buy full or part rights to the SME and its products along with intellectual property under acquisition agreement. The potencial partner's role is responsible and comprehensive involvement in the development and commercialization of selected company projects.
    Potencial partner can be:
    • Biotechnology companies acquiring recipes and IP from the market, which provide the new technologies, innovative products and solutions to pharmaceutical companies.
    • Pharmaceutical and veterinary concerns
    • Companies seeking innovative solutions and technologies in the field of human and veterinary medicinepp500 MNE,251-500,SME 51-250,500p
  • Partnerships
    • Acquisition agreement
Uitgevoerd door:
In opdracht van: